Physical and functional interaction between p53 and the Werner's syndrome protein

被引:138
作者
Blander, G
Kipnis, J
Leal, JFM
Yu, CE
Schellenberg, GD
Oren, M [1 ]
机构
[1] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel
[2] Vet Affairs Med Ctr, Seattle, WA 98108 USA
[3] Univ Washington, Dept Med, Seattle, WA 98195 USA
[4] Univ Washington, Dept Neurol, Seattle, WA 98195 USA
[5] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA
关键词
D O I
10.1074/jbc.274.41.29463
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Werner's syndrome is a human autosomal recessive disorder leading to premature aging. The mutations responsible for this disorder have recently been localized to a gene (WRN) encoding a protein that possesses DNA helicase and exonuclease activities. Patients carrying WRN gene mutations exhibit an elevated rate of cancer, accompanied by increased genomic instability. The latter features are also characteristic of the loss of function of p53, a tumor suppressor that is very frequently inactivated in human cancer. Moreover, changes in the activity of p53 have been implicated in the onset of cellular replicative senescence. We report here that the WRN protein can form a specific physical interaction with p53. This interaction involves the carboxyl-terminal part of WRN and the extreme carboxyl terminus of p53, a region that plays an important role in regulating the functional state of p53. A small fraction of WRN can be found in complex with endogenous p53 in nontransfected cells. Overexpression of WRN leads to augmented p53-dependent transcriptional activity and induction of p21(Waf1) protein expression. These findings support the existence of a cross-talk between WRN and p53, which may be important for maintaining genomic integrity and for preventing the accumulation of aberrations that can give rise to premature senescence and cancer.
引用
收藏
页码:29463 / 29469
页数:7
相关论文
共 68 条
  • [1] INCREASED ACTIVITY OF P53 IN SENESCING FIBROBLASTS
    ATADJA, P
    WONG, H
    GARKAVTSEV, I
    VEILLETTE, C
    RIABOWOL, K
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (18) : 8348 - 8352
  • [2] SUPPRESSION OF HUMAN COLORECTAL-CARCINOMA CELL-GROWTH BY WILD-TYPE-P53
    BAKER, SJ
    MARKOWITZ, S
    FEARON, ER
    WILLSON, JKV
    VOGELSTEIN, B
    [J]. SCIENCE, 1990, 249 (4971) : 912 - 915
  • [3] ISOLATION OF HUMAN-P53-SPECIFIC MONOCLONAL-ANTIBODIES AND THEIR USE IN THE STUDIES OF HUMAN P53 EXPRESSION
    BANKS, L
    MATLASHEWSKI, G
    CRAWFORD, L
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1986, 159 (03): : 529 - 534
  • [4] Bennett WP, 1999, J PATHOL, V187, P8, DOI 10.1002/(SICI)1096-9896(199901)187:1<8::AID-PATH232>3.0.CO
  • [5] 2-Y
  • [6] PHENOTYPIC CHARACTERIZATION OF KU812, A CELL-LINE IDENTIFIED AS AN IMMATURE HUMAN BASOPHILIC LEUKOCYTE
    BLOM, T
    HUANG, RY
    AVESKOGH, M
    NILSSON, K
    HELLMAN, L
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1992, 22 (08) : 2025 - 2032
  • [7] Bond J, 1996, ONCOGENE, V13, P2097
  • [8] BOND JA, 1995, CANCER RES, V55, P2404
  • [9] HOMOLOGOUS RECOMBINATION IS ELEVATED IN SOME WERNER-LIKE SYNDROMES BUT NOT DURING NORMAL INVITRO OR INVIVO SENESCENCE OF MAMMALIAN-CELLS
    CHENG, RZ
    MURANO, S
    KURZ, B
    REIS, RJS
    [J]. MUTATION RESEARCH, 1990, 237 (5-6): : 259 - 269
  • [10] DAP-kinase is a Ca2+ calmodulin-dependent, cytoskeletal-associated protein kinase, with cell death-inducing functions that depend on its catalytic activity
    Cohen, O
    Feinstein, E
    Kimchi, A
    [J]. EMBO JOURNAL, 1997, 16 (05) : 998 - 1008